Results

Total Results: 1,613 records

Showing results for "adverse events".
Users also searched for: patient safety indicators

221. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_disposition-comments.pdf
     October 01, 2010 - of the various adverse events were not always comparable." … Limitations of evaluation of adverse events have been added to Discussion section. … Discussion Adverse effects: “There is a moderate level of evidence to show that adverse events associated … These long-term adverse events need to be explored in future studies. … types of adverse events were different between groups, as would be expected.

222. Tympanostomy Tubes in Children with Otitis Media | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/tympanostomy-tubes/research-2017
     May 05, 2017 - Benefits of TT placement must be weighed against a variety of adverse events. … with chronic otitis media with effusion and recurrent acute otitis media, summarize the frequency of adverse … The benefits of TT placement must be weighed against a variety of adverse events.

223. Topic Coming Back CER 28 DMARDs in Children with JIA NSD _SJ Clean (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_overview.pdf
     March 27, 2014 - In children with JIA, does the rate and type of adverse eventsf differ between the various DMARDs or … How do the efficacy, effectiveness, safety, and adverse effects of treatment with DMARDs differ among … with DMARDs, we focused primarily on serious infections and the development of cancer when assessing adverse … events. … Other adverse events considered included mortality, hepatitis, bone marrow suppression, nausea or vomiting

224. Comparative Effectiveness of Surgical Options for Inguinal Hernia | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/inguinal-hernia/research-protocol
     April 11, 2011 - Adverse events include any unintended effects such as chronic pain, infection, small-bowel perforation … The following will always be considered objective outcomes: adverse events, hospital stay, office visits … This item will only be used for the following outcomes: hernia recurrence, adverse events, QOL, FCT, … Other adverse events. … events.

225. Arthritis-Psoriatric Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-psoriatric_executive.pdf
     April 01, 2012 - events, and specific adverse events if data were available (e.g., injection-site reactions, infections … Compared with placebo, leflunomide led to higher rates of withdrawals because of adverse events, diarrhea … - controlled trials, where adverse events were not the primary outcome. … Overall adverse event profiles appeared to be similar for biologic DMARDs and placebo. … Information generally was insufficient for the comparative harms, tolerability, adverse events, and

226. Appendixes A-I (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-annual-update2-appendices.pdf
     January 16, 2023 - events and withdrawals due to adverse events for each included study. … Events and Withdrawals Due to Adverse Events Bestard, 2011 Moderate Prospective cohort Neuropathic … Events and Withdrawals Due to Adverse Events Lee, 2021b Moderate Matched cohort NR A: Chronic … scale; WAE = withdrawal due to due adverse events. … events; THC = tetrahydrocannabinol; WAEs = study withdrawals due to adverse events.

227. Topic-Brief1-Care-Coordination (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/topic-brief1-care-coordination.pdf
     April 01, 2021 - events) … events, readmissions, and increased costs. … events? … events). … events?

228. Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin II Receptor Antagonists (ARBs) for Treating Essential Hypertension | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/ace-inhibitor-arb-2007/research-2007-1
     November 01, 2007 - regarding their relative benefits (blood pressure control, cardiovascular risk reduction, cardiovascular events … , quality of life, and other outcomes), as well as relative risks (safety, adverse events, tolerability

229. Intravascular Diagnostic Procedures and Imaging Techniques Versus Angiography Alone in Coronary Artery Stenting: Comparative Effectiveness Review | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/coronary-artery-stenting/research
     February 26, 2013 - FFR confers a lower risk of the composite endpoint of death or myocardial infarction (MI) or of major adverse … cardiac events; and (c) FFR leads to fewer stents implanted and reduces the cost of the procedure. … cardiac events or its individual components. … intermediate coronary lesion confers a lower risk of composite endpoint of death or MI, or of major adverse … cardiac events; leads to fewer stents being implanted; and reduces procedural costs.

230. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/thromboembolism-update_research-protocol.pdf
     February 17, 2016 - events? … events. … events due to mechanical devices (as reported by authors) o   Adverse events due to IVC filter (as … reported by authors) o   Other clinically significant adverse events reported by studies … events.

231. Systematic Review on Nonopioid Pharmacologic Treatments for Chronic Pain: Surveillance Report 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-1-nonopioid-pharm-chronic-pain.pdf
     April 01, 2022 - adverse events according to drug class? … Harms and Adverse Events a. … adverse events, according to drug class? … events, and serious adverse events. … Specific adverse events for each drug class, such as gastrointestinal events, cardiovascular events,

232. Pneumonia-Antibiotic-Treatment Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/pneumonia-antibiotic-treatment_executive.pdf
     November 01, 2014 - Rates of antibiotic-related adverse events? Key Question 2. … Rates of antibiotic-related adverse events? Key Question 3. … events, or infusion-related adverse effects. … reactions 1 RCT (n=20) Medium NA Unknown Imprecise Insufficient Adverse events attributed to the … dosing regimen of ceftazidime 1 RCT (n=24) Medium NA Unknown Imprecise Insufficient Adverse events

233. Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 3 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3.pdf
     May 01, 2022 - , nausea, sedation) and study withdrawal due to adverse events. … events, and withdrawals due to adverse events for each included study. … a Other serious adverse events (i.e., psychosis and cannabis use disorder) not reported in any study. … ; VAS = visual analog scale; WAE = withdrawal due to due adverse events. … scale; WAE = withdrawal due to due adverse events.

234. Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 3 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3_0.pdf
     May 01, 2022 - , nausea, sedation) and study withdrawal due to adverse events. … events, and withdrawals due to adverse events for each included study. … a Other serious adverse events (i.e., psychosis and cannabis use disorder) not reported in any study. … ; VAS = visual analog scale; WAE = withdrawal due to due adverse events. … scale; WAE = withdrawal due to due adverse events.

235. Disease-Modifying Antirheumatic Drugs (DMARDs) in Children With Juvenile Idiopathic Arthritis (JIA) | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/juvenile-arthritis-dmards/research
     September 26, 2011 - No comparator was required for reports of adverse events or of the clinical outcome measure tools. … Reported rates of adverse events are similar between DMARDs and placebo in nearly all published randomized

236. Procalcitonin-Guided Antibiotic Therapy | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/procalcitonin/research
     October 05, 2012 - Outcomes were antibiotic use, mortality, morbidity, and adverse drug events of antibiotic therapy. … future research are the consequences of reduction in antibiotic use for antibiotic resistance and for adverse … events of antibiotic therapy.

237. Evaluation of Effectiveness and Safety of Antiepileptic Medications in Patients with Epilepsy | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/epilepsy-medicine/research-protocol
     July 01, 2010 - events such as neurological adverse effects, hypotension, rash, suicidal ideation, mood and cognition … Based on the comments received and input from the Technical Expert Panel, the adverse events listed under … effects Cosmetic adverse events Incidence of adverse events Incidence of individual adverse events … Incidence of adverse events resulting in therapy withdrawal Incidence of adverse events not resulting … in therapy withdrawal Skin rash Neurological adverse events Suicidal ideation Health-related

238. Cannabis-2022-Surv-Rep-4-Table-F5 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-table-F5.xlsx
     January 01, 2022 - Events Other Reported Outcomes Funding Source Risk of Bias 21087411 Bestard, 2011 Prospective cohort … C % (n/N) Any adverse event 3 months: 35% (19/49) vs. 47% (30/52) vs. NR, RR for A vs. … B 0.72 (95% CI 0.49 to 1.07) Serious adverse events: none in any group Withdrawals due to adverse events … adverse events: 13% (28/215) vs. 19.4% (42/216), RR 0.67 (95% CI 0.43 to 1.04) Withdrawals due to adverse … events: 4.65% (10/215) vs.

239. Cannabis-2023-Surv-Rep-4-Table-E-5 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-table-E-5.xlsx
     January 01, 2023 - Events Other Reported Outcomes Funding Source Risk of Bias 21087411 Bestard, 2011 Prospective cohort … C % (n/N) Any adverse event 3 months: 35% (19/49) vs. 47% (30/52) vs. NR, RR for A vs. … B 0.72 (95% CI 0.49 to 1.07) Serious adverse events: none in any group Withdrawals due to adverse events … adverse events: 13% (28/215) vs. 19.4% (42/216), RR 0.67 (95% CI 0.43 to 1.04) Withdrawals due to adverse … events: 4.65% (10/215) vs.

240. Executive Summary: ADHD Diagnosis and Treatment in Children and Adolescents (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-267-adhd-executive-summary.pdf
     March 01, 2024 - • The identified diagnostic studies did not assess the adverse effects of being labeled correctly … events … Furthermore, the identified studies did not assess the adverse effects of being labeled correctly or … events, such as appetite suppression (RR 0.82; CI 0.53, 1.26, 8 studies, n=1463; low SoE). … Across studies, medication therapy evaluations reported more adverse events than non-medication interventions